Arzerra Third Quarter 2011 Net Sales Figures

Arzerra worldwide net sales in Q3 2011 totaled GBP 11.9 million (DKK 101.4 million) Genmab expects royalty payment of DKK 20.3 million COPENHAGEN, Denmark, Oct. 26, 2011 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced today that the Arzerra(r) (ofatumumab) net sales during the third quarter of 2011 were GBP 11.9 million (approximately DKK 101.4 million). This figure consists of net sales in the U.S. of GBP 8.5 million (approximately DKK 72.2 million) and in the rest of the world...continued GNMSF GNMSY

URL: http://www.investorpoint.com/news/INTHPINK/45543643/